Moderate or more severe COVID-19 linked to primary outcome while mild, asymptomatic infection was not
Humoral Response in Hemodialysis Patients Stronger With mRNA-1273
Antibody responses at six to seven and 12 weeks after the second dose stronger with mRNA-1273 versus BNT162b2
Vaccination in Pregnancy Prevents COVID-19 Hospitalization in Infants
Maternal completion of two-dose primary mRNA COVID-19 vaccination series 61 percent effective for preventing COVID-19 hospitalization